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ABSTRACT 
 
PREDICTORS OF LYME ARTHRITIS DIAGNOSIS 
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WILLIAM LAPSLEY, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Dr. Brian Whitcomb 
 
 
 Lyme disease is the most common vector-borne disease in the United States with 
over 20,000 cases reported yearly. A common and sometimes severe symptom of Lyme 
disease is Lyme arthritis, which has clinical and etiological similarities to rheumatoid 
arthritis. While risk factors for Lyme disease are established, there have been no studies 
exploring risk factors for Lyme arthritis. To assess this relationship a cross-sectional 
study was conducted, using data from confirmed cases of Lyme disease reported to the 
Massachusetts Department of Public Health (MDPH) from 2000 to 2006. Bivariate 
analyses and ANOVA tests were conducted to assess the relationship between age, sex 
and Lyme arthritis, as well as other symptoms of Lyme disease. Results showed that 
those in the lowest quartile of age were more likely to be diagnosed with Lyme arthritis 
alone than those in higher age quartiles (p <0.001). No significant difference was seen in 
the proportion of Lyme arthritis diagnosis between males and females (p = 0.61). By 
recognizing that younger patients with Lyme disease are more likely to be diagnosed with 
Lyme arthritis, measures may be taken to improve early identification and treatment of 
Lyme disease in this group. We recommend that a future prospective study be conducted 
to further elucidate the true relationships between age, sex, and Lyme arthritis.  
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CHAPTER I 
INTRODUCTION 
 
 Lyme disease (LD), caused by the bacteria Borrelia burgdorferi, is the most 
common vector-borne disease in the United States, with an average of over 20,000 cases 
reported annually since 2002 [1]. Many of these cases occur in the New England and 
Mid-Atlantic regions, as well as in Wisconsin and Minnesota [1].  In 2007, Massachusetts 
had an incidence rate of 46.3 cases per 100,000 people, compared to the national rate of 
9.1 cases per 100,000 [1]. Due to the highly endemic nature of LD in Massachusetts it is 
vital that we recognize the risks of contracting this disease and the benefits of diagnosing 
it early. 
A major symptom of LD is Lyme arthritis (LA), which is reported in roughly one-
third of all LD cases and up to 60% of untreated cases [1, 2]. The manifestations of this 
form of arthritis include swelling and pain in the large joints, especially the knees [2]. 
These symptoms typically take place in the late stage of infection, arising weeks to years 
after initial infection [18]. Due to LA being a late stage symptom it is clear that early 
diagnosis and treatment are essential to LA prevention. Most LD and LA cases can be 
treated effectively with antibiotics in the early stages of infection. However, about 10% 
of individuals may experience bouts of chronic inflammation lasting months to years [3]. 
This long-term repercussion of LD infection has been termed chronic LA or antibiotic-
treatment-resistant LA [4]. 
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 Lyme arthritis closely mimics rheumatoid arthritis (RA) in two ways. First, the 
inflammatory symptoms associated with LA closely resemble those of RA as they can 
flare up and then be followed by periods of remission [3, 4]. Secondly, particular antigen-
presenting HLA class II molecules that are associated with treatment-resistant LA have 
also been implicated with increased susceptibility and severity of RA [5-7]. These two 
forms of arthritis differ in that B. burgdorferi is the initial cause of LA, while the true 
cause of RA remains unclear. 
 Due to the similar clinical pathology and genetic risk factors of these two forms of 
arthritis (particularly in the case of chronic LA), LA cases may have similar risk factors 
to those for RA cases. While high-risk groups have been identified for RA, risks for LA 
have been largely disregarded. Because of this discrepancy in established knowledge, 
coupled with variability and difficulty associated with LD diagnosis, my hypotheses for 
LA are to an extent, based on what is known about age and sex as risk factors of RA.  
 To assess this relationship a cross-sectional study design was used, utilizing Lyme 
disease case data obtained from the Massachusetts Department of Public Health (MDPH) 
from 2000 to 2006 to assess the relationship between age, sex and LA. 
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CHAPTER II 
LITERATURE REVIEW 
 
Physiology of Exposure-Outcome Relationship: 
 While it is recognized that RA is an autoimmune disease, its cause remains 
unclear [4]. On the other hand, the initial cause of LA is the presence of B. burgdorferi in 
the joints, though chronic or treatment-resistant forms of LA may be caused by 
autoimmune responses [5].  
 Age is a well-established risk factor for RA, with the majority of cases arising 
between the ages of 40-60 years old [4]. There is limited evidence, however, to assess if 
age is also a risk factor for LA in LD cases. In older populations more individuals may 
have weakened immune systems due to chronic illness, immunosuppressive 
chemotherapy, or simply due to advanced age. As a corollary, those individuals will be 
more prone to disseminating B. burgdorferi infection, and therefore LA, compared to 
their younger and healthier counterparts. Also, as people advance in age they may 
become more likely to experience chronic LA due to autoimmune reaction, as is the case 
with RA [4, 13]. 
 Sex is another recognized risk factor for RA that has garnered little attention with 
LA. In the case of RA, women have up to four times the risk as men in some populations 
[8, 9]. While there is no clear reason for this, it is hypothesized that hormonal factors play 
a role in female susceptibility [10]. Genetic predisposition is also a factor in RA as the 
presence of HLA-DRB1 alleles have shown to increase susceptibility and severity of 
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disease [6]. Distribution of these alleles may differ, or appear in different combinations, 
between men and women, leading to varying outcomes between sexes [6, 11, 12]. 
 In summary, due to the similar biological similarities between LA and RA, age 
and sex may be analogous risk factors between these two forms of arthritis, especially in 
cases of treatment-resistant LA. 
 
Epidemiology of Exposure-Outcome Relationship: 
  Epidemiological data concerning LA in particular are quite sparse. While a 
number of studies have been performed on the topic of LD, research has seldom 
evaluated the distribution of LA among those cases. Because age and sex are established 
risk factors for RA, these variables are rarely the main exposures of interest in recent 
studies. Indeed, in the majority of studies age and sex are controlled for to determine the 
effects of other variables. Therefore, due to the lack of epidemiological studies directly 
pertaining to age and gender as risk factors for LA, we will present studies evaluating age 
and gender as risk factors for LD and RA to make indirect inferences on LA [13-15]. 
 A prospective cohort study conducted by Chan et al. was designed to determine 
the incidence of RA according to age and sex in central Massachusetts from 1987 to 1990 
[13]. The study included members of the Fallon Community Health Plan (FCHP), 
primarily residing in Worcester County, MA. Over the course of the study, FCHP 
membership increased from 77,000 individuals in 1987 to 126,000 in 1990. Potential 
cases were queried from the research database by identifying all FCHP members with at 
least 1 provisional or hospital diagnosis of RA during the study period. A case of RA was 
defined as an adult (older than 18) member of FCHP whose symptoms fit the criteria for 
 5 
either the 1958 or 1987 American College of Rheumatology definition of RA. Because 
incident, not prevalent, cases were the object of the study, any members identified as RA 
cases at the beginning of the study were dropped from the analysis. Incidence rates were 
calculated by dividing the number of new cases in each age-sex category by membership-
years at risk. Calculations were based on the assumption that case counts followed a 
Poisson distribution and all results were age- and sex-standardized to the 1980 US white 
population. Over the course of the study period, 81 members (22 men and 59 women) 
were diagnosed as having incident RA. Age-specific annual incidence was highest among 
the 60-69 year old age group at 97 cases per 100,000. This varied sharply from an 
incidence rate of 5 cases per 100,000 in the18-29 age group. Women had 2-3 times the 
risk of RA as compared to men at all levels of age. The overall age-standardized 
incidence rates per 100,000 were 22 (95% CI 13-32) for men and 60 (95% CI 46-75) for 
women. This study reinforces the finding that age and sex are established and important 
risk factors for RA.  
 In a prospective cohort study conducted around Paris, France, Dhote et al. aimed 
to determine the clinical and epidemiological features of Lyme borreliosis in the area 
between 1989 and 1997 [14]. Patients were recruited from various wards in a public 
hospital in Paris and cases were verified by assessing a combination of clinical symptoms 
and serological tests. Lyme arthritis was defined in this cohort as the presence of synovial 
inflammation, with chronic LA defined as synovitis persisting at least 6 months. Of the 
170 patients that were diagnosed with Lyme borreliosis, 34 (20%) were also diagnosed 
with LA, which is somewhat lower than the percentage typically seen in the United States 
[1]. The mean age of cases with LA was 44 (SD = 18.8) years old. In terms of the gender 
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distribution, 9 (26%) were females and the other 25 (74%) were males. Though this 
difference found between males and females is considerable, Dhote provides no theories 
to explain this finding. A possible reason for this gender difference may be that the 
pathogen interacts differently between male and female host environments due to 
hormonal factors. While this study assessed the distribution of LA, it must be noted that 
European forms of Lyme borreliosis are caused by different species of B. burgdorferi 
than are found in the US, so results may lack generalizability. Also, due to the relatively 
small sample size, the study lacks the power to make significant conclusions. 
 A study was performed by Petersen et al. in which LD cases identified by active 
surveillance were analyzed to assess the incidence and epidemiology of LD and its 
symptoms [15]. The study was carried out in Connecticut during 1984 and 1985, and 
obtained a total of 1,149 defined LD cases. Data on patients were gathered by the 
Connecticut State Department of Health Services from physician case report forms paired 
with specimens sent to the state laboratory. To meet the case definition an individual had 
to have at least one clinical manifestation commonly associated with LD and at least one 
positive serological test result. Serological laboratory tests included either an indirect 
immunofluorescence assay (IFA) or an enzyme-linked immunofluorescence assay 
(ELISA). Results showed that 252 (24%) of LD cases presented the symptom of LA. Of 
these 252 cases, 113 were under the age of 20 and the remaining 129 were 20 or older. 
Persons less than 20 years old were nearly twice as likely to be diagnosed with LA as 
those 20 or older (RR = 1.9; 95% CI 1.5-2.3). This finding may be the result of 
surveillance bias due to a heightened awareness of LA among children, who are less 
likely to have joint aches and pains than older people.  
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 In general, the studies cited here found that women and older people were at 
higher risk of contracting RA, which is not the same disease as LA, though they share 
some etiological similarities, especially in the case of chronic LA. Also, men and those 
under 20 years old were at higher risk of experiencing LA. Failure to adjust for potential 
confounding and effect modifying variables may have hidden or skewed the 
interpretation of the relationships found in these studies. They may also be subject to 
biases that were not controlled for in the designs. Due to these shortcomings, the true 
associations between age, sex, and LA remain unknown.  
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CHAPTER III 
SUMMARY 
 
 Lyme disease is a growing concern in the United States with over 20,000 cases 
occurring annually. Of these LD cases, many suffer from arthritis due to B. burgdorferi 
infection. Despite the considerable morbidity caused by LA, little attention has been paid 
to understanding its risk factors. From what scant data has been collected it appears that 
LA has a tendency to affect males more often than females. However, when looking at 
the incidence of RA, which shares biological similarities with LA, rates are much higher 
in women. Also, while increasing age has been shown to increase the risk of RA, the 
opposite has been found for LA in at least one instance. The lack of definitive 
epidemiological evidence suggests that more research is needed to assess what roles age 
and sex play in the manifestation of LA. In light of the paucity of quality studies on this 
topic, an accurate analysis focusing on LA, as opposed to LD, is necessary to better 
elucidate the relationships between age, sex, and LA.  
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CHAPTER IV 
AIM AND HYPOTHESES 
 
Specific Aim: 
 To evaluate age and sex as predictors of Lyme arthritis diagnosis in patients who 
have contracted Lyme disease. 
 
Hypotheses: 
1. Among those with Lyme disease, age will be positively correlated to diagnosis 
of Lyme arthritis. 
2. Among those with Lyme disease, females will be diagnosed with Lyme 
arthritis more often than males. 
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CHAPTER V 
 
METHODS 
 
 
Study Design: 
 
 To examine the associations between age, sex, and the diagnosis of LA in patients 
with LD, a cross-sectional study was conducted utilizing data obtained from the 
Massachusetts Department of Public Health (MDPH) that encompassed the years 2000 to 
2006. Massachusetts state regulations place LD on its list of reportable diseases (105 
CMR 300.100) and require that local boards of health promptly report any cases or 
suspected cases to the MDPH (105 CMR 300.110) [16]. Physicians generally contact 
local health agents to notify them of suspected cases, at which point it is the health 
agents’ responsibility to fill out a case report form using information from the physician 
or the case, and send it to the MDPH. At the MDPH, report forms are compiled, 
reviewed, and transcribed into a database. Case report forms include patient information 
on demographics and clinical information relating to LD, as well as symptom onset and 
diagnosis dates (Figure 1). Due to the lack of reliable biological information obtained 
from the case report forms it was impossible to make substantial claims about how age 
and sex truly affect the risk of acquiring LA. However, with the data available, I aimed to 
assess how these variables play a role in the diagnosis of LA. 
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Population and Eligibility: 
  This study was based on LD cases reported to the MDPH between the years 2000 
and 2006. Lyme disease is endemic throughout the state, so exposure was not limited to 
any specific group. However, those living in metropolitan areas are less likely to contract 
LD around their homes due to the sylvatic nature of tick and their usual hosts.  
Each year the MDPH receives an average of 10,000 LD reports from local health 
agents and physicians, which are then validated by a team of epidemiologists and 
assigned a case status of  “confirmed,” “probable,” “suspect,” or “revoked,” based on a 
combination of clinical and laboratory results. In this study we included only cases that 
were deemed as “confirmed” by the MDPH. Also, LD cases with unknown LA status and 
those with incomplete covariate data were excluded from analysis. 
 
Outcome Assessment: 
 Lyme arthritis is recorded in LD case report forms that have been filled out by 
town health agents or physicians. On the form, LA can be coded as yes, no, or unknown, 
though individuals with unknown status were excluded from the study as noted earlier 
(Table 1). The symptom is used as an element in the diagnostic assessment of LD, so 
physicians should be alert to the potential for LA in suspected LD cases. Clinical features 
of LA are typified by recurrent, brief (weeks to months) bouts of swelling and pain in the 
joints, particularly the knees.  
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Outcome validation: 
Lyme arthritis is generally diagnosed by clinical means and is dependent on 
having a primary diagnosis of LD. Lyme disease is validated by physician diagnosis and 
is based on an algorithm that includes the presence of an erythema migrans rash of at 
least 5cm in diameter, or by a combination of late-manifesting LD symptoms in addition 
to a positive laboratory test. Laboratories test serum for the presence of diagnostic levels 
of IgG or IgM antibodies to Borrelial antigen. Initial testing is done using ELISA or IFA 
techniques, and samples with positive or equivocal results are then re-tested using 
Western blot procedure [16, 17]. Unfortunately, these tests are not always accurate. For 
example, they are particularly insensitive in the early stages of infection and cannot 
distinguish between past and present infection. Also, false positives may occur due to 
cross-reactivity with antibodies being produced against diseases such as RA, lupus, and 
mononucleosis, among others. Another diagnostic method is to isolate B. burgdorferi 
itself from a clinical specimen [18]. 
 
Exposure Assessment: 
 Assessment of the exposures of age and sex is also based on data from case report 
forms. In this study, age in years will be divided into quartiles and sex will be classified 
as male or female (Table 1).  
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Exposure validation: 
Reporting of these variables should be accurate in forms submitted by physicians 
due to their access to patient medical charts. For local health agents it may be more 
challenging to accurately characterize features of LD cases, as they may not meet all 
cases face to face.  
 
Covariate Assessment: 
 A number of covariates were included in the analysis based on their roles as 
diagnostic elements for LD and their temporal relation to LA. These variables include the 
presence of erythema migrans rash, Bell’s palsy, and the number of months between 
symptom onset date and diagnosis date (Table 1). Again, data for these variables were 
obtained from a compilation of MDPH Lyme disease case report forms.  
 
Data Analysis: 
 
 
Univariate Analysis: 
 We first determined the total number of study participants and made exclusions 
due to missing or unknown LA status, as well as missing or unknown covariate data 
leading to the final study population of individuals having complete data (Table 2). 
Because the study population was obtained via case report forms, patient refusal was not 
a concern. Next, the number and percentage of people in the exposure (age, sex) and 
outcome (LA) groups for our study population was calculated (Table 3). The total 
number and percent of people with each symptom, or combination of symptoms, was also 
determined (Table 4). 
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Bivariate Analysis: 
 Analyses were conducted to specifically determine if the proportion of individuals 
with each symptom, or group of symptoms, differed across strata of age, sex, and number 
of months between symptom onset and diagnosis (Table 5-7). Chi-squared tests were 
used to assess significance, as well as Fischer’s Exact test where cell counts were less 
than 5. 
 
Additional Analyses: 
 
 Least squares means were calculated using ANOVA to determine the mean ages 
of individuals having each symptom, or combination of symptoms. P-values were 
obtained for Dunnett post-hoc comparisons of means, with erythema migrans used as the 
referent against which the means of all other symptoms were compared (Table 8). The 
same analysis was run to assess the mean number of months between onset of symptoms 
and diagnosis for each symptom, both with and without individuals having a time 
difference of 36 months or more (Table 9).  
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CHAPTER VI 
SIGNIFICANCE 
 
 Risk factors for LA have largely been overlooked in prior studies involving LD. 
This study aimed to elucidate the role that age and sex play in the diagnosis of LA. From 
our findings we may be able to heighten awareness about LD in high-risk groups or even 
target these people for more aggressive anti-arthritis treatment at first onset of LD, thus 
reducing morbidity due to LD. These measures could be especially effective in highly 
endemic areas such as southeastern Massachusetts. 
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CHAPTER VII 
HUMAN SUBJECT PROTECTION AND PERMISSION TO ACCESS DATA 
 
Human Subjects Protection: 
 All potential case-identifying information was removed from the data set, as 
overseen by members in the Privacy and Data Access Office and the Office of Integrated 
Surveillance and Informatics Services at the Massachusetts Department of Public Health. 
 
Permission to Access Data: 
 Permission to access data was granted by the Massachusetts Department of Public 
Health. 
 
 
 
 
 
 
 
 
 
 
 
 
 17 
CHAPTER VIII 
RESULTS 
 
 
 The original study base included all individuals recorded by the MDPH as being 
diagnosed with LD from the year 2000 to 2006 (n = 12500). Of these LD cases, 4074 
were excluded due to missing or unknown LA status, and an additional 4187 were 
excluded due to missing exposure variable data, leaving 4329 individuals for inclusion in 
the final analysis (Table 2).  The age of this population ranged from 0 to 99 years old, 
with a mean age of 35.9 (SD = 23.1).  The study included 2366 males and 1873 females, 
accounting for 55.8% and 44.2% of the population respectively. Of these individuals, 
1680 (39.6%) were diagnosed with LA (Table 3). The distribution of symptoms among 
the entire population showed that 2055 (49.6%) had erythema migrans as their only 
symptom, 282 (6.8%) had Bell’s palsy as their only symptom, and 1087 (26.3%) had LA 
as their only symptom. Only 59 (1.4%) individuals diagnosed with LD were also 
diagnosed with all three of the main symptoms of interest (Table 4). 
 Symptoms were broken down into seven specific categories to distinguish those 
with single symptoms (3 groups) and those presenting multiple symptoms (4 groups). 
Stratification by age showed no change between quartiles for erythema migrans 
(p=0.563), but significant changes for Bell’s palsy and LA (p<0.001 for each) with those 
in the lower quartiles having a higher proportion of being diagnosed with these symptoms 
than their older counterparts. For those with multiple symptoms results were variable, 
however, those in the first age quartile consistently had lower proportions of these 
grouped symptoms than all others (Table 5). When all symptoms were stratified by sex 
there were no significant differences seen except for in the case of Bell’s palsy, in which 
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females were diagnosed with this more often than males (p = 0.011) (Table 6). Stratifying 
symptoms by time from symptom onset to diagnosis with LD yielded some significant 
results. As the number of months between onset and diagnosis increased for erythema 
migrans and Bell’s palsy the proportions of individuals presenting those symptoms 
decreased (p<0.001). The opposite was seen for LA, where only 21.6 percent had LA 
where diagnosed with LD occurred in the same month as symptom onset, while 36.6 
percent had LA in those where LD diagnoses occurred at least 7 months after symptom 
onset (p<0.001). For those presenting the combinations of EM+LA and BP+LA similar 
trends were seen as that for LA only (Table 7). 
 Comparing the mean age of individuals at the time of LD diagnosis based on their 
symptoms showed that those with Bell’s palsy only or LA only were significantly 
younger than those with erythema migrans only (p<0.001 and 0.011 respectively). Also, 
individuals with multiple symptoms tended to be older than those diagnosed with only a 
single symptom, as individuals with erythema migrans, Bell’s palsy, and LA combined 
were an average of 44.0 years old (Table 8). 
 Statistically significant differences were not initially seen when mean number of 
months between symptom onset and diagnosis of LD was looked at between erythema 
migrans and other symptoms, except for in the EM+LA group (p = 0.015). A sensitivity 
analysis was then done removing 33 individuals who had a difference of 36 or more 
months between symptom onset and diagnosis. After removal of these individuals similar 
means were still seen between erythema migrans and Bell’s palsy (p = 0.642) while LA 
became significantly different (p<0.001) (Table 9). 
 19 
 Individuals with complete data (n = 4329) differed significantly from those with 
incomplete data (n = 4187) in many respects, including the presence of LA, Bell’s palsy, 
erythema migrans, and mean age. Months between symptom onset and diagnosis was 
significant among the two groups (p = 0.049) and male-female distribution was not found 
to be significantly different (p = 0.457) (Table 10). 
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CHAPTER IX 
 
DISCUSSION 
 
 
The findings of this cross-sectional study suggest that children in the first age 
quartile (aged 0-14) who contract LD are more likely to be diagnosed with LA than older 
individuals. This finding is the opposite of what was hypothesized at the beginning of the 
study. It does, however, support the findings by Petersen et al., who had previously 
suggested that those under 20 years old had twice the risk of LA compared to those over 
20. The other main exposure of interest, sex, did not seem to have any appreciable effect 
on LA diagnosis, as the proportions of LA diagnosis were nearly identical between men 
and women. 
Though we found similar results to Petersen et al. regarding LA in children, the 
true cause of this remains to be seen. Like Petersen, we were limited by the surveillance 
data collected and were unable to discover and true biological relations between age and 
LA. While children with LD may truly be more susceptible to LA, the same bias may 
have been present in this study as I suggested for Petersen; that LA would be detected 
more readily in children as it is an unusual symptom in that age group, whereas it may be 
overlooked if it is the only symptom present in an older individual where arthritis is more 
common. This hypothesis may be supported by the fact that for individuals with LA in 
combination with another symptom the proportions are higher in older age groups, 
suggesting that LD diagnosis is more dependent on the presence of another symptom to 
go along with LA in older people than it is for children. 
Whether LD cases were male or female, they were diagnosed with LA at similar 
rates. There is no obvious reason why actual physician diagnosis should be differential 
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between males and females, as the diagnostic criteria is the same for both sexes. Though 
we do not know if there is a true difference in susceptibility between males and females 
due to genetic or hormonal factors, we can infer from our results that such a difference is 
unlikely.  
Whereas being female dramatically increases the risk of having RA, the same 
does not appear to hold true for LA. Though LA and RA do share some clinical and 
biological similarities, they are truly two different diseases with different causes; LA 
being resultant of a bacterial infection and RA resulting from autoimmunity. Because of 
this, gender may have had less of an effect than originally hypothesized. While the 
findings of Dhote et al. suggested that females had roughly one-third the risk of 
presenting LA as males, a logical conclusion may be that the gender distribution found by 
Dhote was a product of chance, due to the small sample size of the study. 
 The mean age at diagnosis for erythema migrans (36.2 years) being so close to the 
mean age of the total population (35.9 years) provides further evidence that erythema 
migrans is diagnosed uniformly across all age strata. An interesting feature regard mean 
ages was that those with multiple symptoms tended to be older than those with single 
symptoms. This may be a product of the fact the younger people exhibiting the symptoms 
of Bell’s palsy or arthritis may be recognized as LD cases more readily based on a single 
symptom than in older people, where these symptoms are generally more common, and 
may necessitate a supplementary symptom to arise before a doctor is willing to diagnose 
them with LD. 
 The results from looking at the mean number of months between symptom onset 
and LD diagnosis suggest that those with LA, whether alone or in concert with other 
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symptoms, significantly delays diagnosis time. One explanation for this is that LA 
typically takes a number of weeks to months to manifest itself, which is usually longer 
than it takes for erythema migrans or Bell’s palsy to be diagnosed. 
 
Limitations: 
 This study is limited by the incomplete nature of the data. With nearly two-thirds 
of the initial study base excluded from the final analysis there is a large potential for bias 
in the results, especially as those with complete data and those with incomplete data are 
significantly different in the distribution of LA, Bell’s palsy, and erythema migrans as 
well as age. 
 
 
Non-differential misclassification of exposure: 
 On the case report forms sent to the MDPH, patient date of birth is recorded 
instead of age. In this data set, patient age was derived from date of birth by the MDPH.  
Age may be misclassified if the person converting date of birth information into age 
made a typological or mathematical error. This is unlikely to be an issue, however, 
because age is stratified into four levels in this study, so only those whose age changed 
them from one group to another due to rounding error are of concern. Another potential 
for misclassification of age is if people falsely reported their date of birth to the medical 
doctor or local health agent filling out the case report form. In the case of a report from a 
doctor, this seems to be an unlikely scenario as a doctor would have had access to the 
patients’ medical charts at the time of diagnosis and therefore, would have been able to 
accurately report date of birth. Reports taken by health agents may have been more prone 
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to misclassification as they may not have bothered, or have had the means, to validate 
patient date of birth. Once again this would have only been an issue in the event that 
misreporting of date of birth caused the individual to change from one of the age quartiles 
into another. It is believed that rounding error and false patient reporting were rare 
occurrences and did not have significant effect on the outcome. 
 Sex is an unlikely source of misclassification. This may have occurred if a 
physician or health agent made a mistake while filling out the case report form and the 
error was not identified.  
 
Non-differential misclassification of outcome: 
  Misclassification of LA may have been a fairly common occurrence for a variety 
of reasons. First, there is no diagnostic tool for LA, and the ones for LD are not perfect. 
This alone may have lead to highly variable diagnoses from one doctor to the next. 
Second, some LD patients may have had a case report form sent in before the symptom 
of LA developed, so true cases would have been counted as non-cases. Another likely 
source of misclassification is that those experiencing LA may have been more likely to be 
diagnosed with LD than those without LA, because the symptom helps to elucidate the 
disease. This means that individuals with LD who had the symptom of LA may be over-
represented. It is likely that misclassification of LA is common in this population and has 
lead to some bias in the results. 
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Selection Bias: 
 One possible form of bias is that older people who truly have LA may have been 
more likely to be misdiagnosed with rheumatoid (or other) arthritis more often than 
younger people, as this is a relatively common disease in those who fall into the highest 
age quartile of this study. If this has occurred it would yield an underestimate of true 
cases of LA in the highest age group. 
 In a similar scenario, women may also have been more likely to be misdiagnosed 
with rheumatoid arthritis compared to men. This could be attributed to the higher rates of 
rheumatoid arthritis seen in women compared to men, which would lead a doctor to more 
readily make that diagnosis. A diagnosis of RA would make it less likely for that person 
to be also diagnosed with LD, so they would be missing from the cohort. Again, if this 
has occurred it would lead to an underestimate of true cases of LA in women and would 
result in biased data. 
 
Information Bias: 
 While it is clear that diagnosis of LA will differ among LD patients it is not clear 
if this will be a product of differing age or sex. One possibility is that general physicians 
may be more likely to recognize the signs of arthritis more readily than a pediatrician, 
which could cause an overestimation of the true relationship between age and LA. It 
seems less likely that sex would play a role in differential diagnosis of LA as men and 
women see the same doctors and currently neither sex is recognized as being at a higher 
risk of LA than the other. 
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Confounding: 
 Though information was collected on a number of variables, some potential 
confounders may exist that we were not able to obtain data for. One factor that likely had 
an effect on the results is treatment status and use of medication. There are multiple 
courses of treatment that doctors may prescribe based on patient age, symptoms, and 
medical history. These differences in treatment regimens may result in varied outcomes 
for the progression of the disease and its symptoms. As a result, there could be either an 
over- or an underestimate of the true relative risk for the associations between age and 
LA, as well as sex and LA. Also, some individuals may have already been taking 
antibiotics that are used to combat LD, such as doxycycline or amoxicillin, before they 
were even bit by a tick as they were being treated for another ailment. This would likely 
have a prophylactic effect and prevent individuals from contracting LD in the first place, 
excluding them from the study population altogether. 
Another potential confounder is cigarette smoking, which has been shown to 
significantly increase the risk of rheumatoid arthritis [20]. As treatment-resistant LA has 
some biological relation to RA, it is predicted that smoking may also lead to higher rates 
of LA. It is expected that those in the upper age groups have had more exposure to 
smoking, meaning that people who are older may be more likely to be (or to have been) 
smokers, which would increase their risk of LA.  
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Generalizability: 
 The results of this study can likely be generalized to other endemic areas of LD in 
the United States. Lyme disease is mostly present along the East Coast from Virginia 
northward to Maine, as well as in the Northern Central states of Wisconsin and 
Minnesota. In these areas the population demographics are similar enough to those of 
Massachusetts that it is not unreasonable to assume generalizability. The findings may 
not be generalizable, however, to non-endemic areas of the United States, as suggested by 
the CDC after conducting a national LD surveillance summary [21]. In non-endemic 
areas population demographics may be significantly different based on age or race. 
Reporting and diagnosis of LD may also differ in areas where the disease is uncommon. 
Lastly, LD in non-endemic areas may be caused by different Borrelia species than are 
found in areas of endemicity. These species may have different tissue tropisms and could 
be more or less likely to cause LA, as in Europe where LA is not a common symptom of 
Lyme borreliosis.  
 
Temporality: 
While temporality is not of great concern in this study in terms of age and sex, it 
is a considerable issue regarding diagnosis for LD, LA, erythema migrans, and Bell’s 
palsy. Because this study was cross-sectional, all data was collected at a single point in 
time, so we do not know what outcomes the patients may have encountered following 
their entrance into the study. For example, an individual who presented erythema migrans 
and was diagnosed with LD may have had a case report sent to the MDPH with that 
information recorded. However, that same person may have later developed LA, though 
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we would have no way of knowing as no additional case report form would have been 
submitted. To be able to truly associate the risk that early symptoms have on LA a 
prospective cohort study would have to be conducted, which followed patients past the 
time of LD diagnosis until the point where symptoms have subsided. 
 
Survival Bias: 
While LD is associated with substantial morbidity its mortality rate is negligible. 
Due to the extremely rare nature of death due to LD we do not believe that survival bias 
was an issue in this study. 
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CHAPTER X 
CONCLUSION 
 
 In conclusion, this study found that a significantly higher proportion of children 
14 years old and younger were diagnosed with LA only, as compared those over 14 years 
old. Our finding was consistent with those of previous LD surveillance studies [15, 21]. 
This consistency, however, may be a product of surveillance or diagnostic bias. Gender 
did not appear to be a significant factor for predicting LA, as males and females had 
nearly identical risks, though a significant difference was seen for Bell’s palsy.  
 There were a number of limitations to this study that prevented us from being able 
to uncover any truly meaningful biological findings. First, we were limited to using data 
provided by the MDPH, which was collected using passive surveillance and did not 
include many variables, such as race, co-infection with other tick-borne diseases, 
serological test results, or any personal or medical information that may have helped to 
elucidate the true relationships between age, sex, and LA. The second issue was that 
many cases had missing data, which drastically reduced the power and validity of the 
study, as those with complete data differed significantly from those with missing data in 
many respects. Lastly and most importantly was the issue of temporality, as patients were 
not followed after their initial LD diagnosis, causing us to miss any LA cases that may 
have developed after a case report form had been submitted to the MDPH. 
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To appropriately assess the risk factors for developing LA we recommend that a 
prospective cohort study be done in the future, following individuals from time of 
infection until abatement of symptoms, and including a larger number of potentially 
confounding medical and lifestyle variables. 
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FIGURE 1: MDPH Lyme Disease case report form 
 
 
